EDIT:NASDAQ
Editas Medicine Inc
1,86 USD
arrow_downward
−0,27%(−0,0050) 1D
17. stu, 13:44:29 GMT -5 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za EDIT...
Otvori
1,90 USD
Najviša
1,94 USD
Najniža
1,82 USD
Trž. kap.
287,84 mil.
Prosj. kol.
2,41 mil.
Količina
1,02 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Otvori
1,90 USD
Najviša
1,94 USD
Najniža
1,82 USD
Trž. kap.
287,84 mil.
Prosj. kol.
2,41 mil.
Količina
1,02 mil.
52-tjed. najviša
3,94 USD
52-tjed. najniža
1,66 USD
EPS
−0,62 USD
Beta
2,09
Dionice u optjecaju
154,34 mil.
Broj djelatnika
87
Vijesti
Iz web-izvora i od partnera za vijesti
ChartMill
·
prije 1 sat
Today's S&P 500 Top Movers: Reddit Leads Gainers, Salesforce Leads Decliners
MarketWatch
·
prije 1 sat
Why Salesforce’s stock is leading S&P 500 decliners amid tech jitters
24/7 Wall St.
·
prije 43 minute
Bill Ackman Cut His Microsoft Stake. Your S&P 500 Fund Can’t.
BigGo Finance
·
prije 1 sat
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc – informacije
Glavni izvršni direktor-
Zaposlenici87
Osnovanostu 2013
Sjedište-
SektorHealth Care
Djelatnost-
Web-lokacijaeditasmedicine.com